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REVUE DE LA LITTÉRATURE / LITERATURE REVIEW
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ADVERSE EFFECTS OF BOTULINUM TOXIN TYPE A
INJECTIONS IN MASTICATORY MUSCLES ON UNDERLYING
BONE AND CARTILAGE: A LITERATURE REVIEW
Camille Haddad * | Stephanie Mrad** | Georges El Najjar***
Abstract
Botulinum toxin type A (BTA) injections in masticatory muscles are used to treat numerous clinical conditions. This neurotoxin causes atrophy and transient
paralysis of the concerned muscles.
The aim of this review is to gather and define the effects of BTA injections in masticatory muscles on the underlying cartilage and bone structures.
Electronic search of Medline and Google scholar databases covering the period between January 2007 and July 2019 was carried out. Eligible articles
were selected according to the inclusion/exclusion criteria. Fourteen articles were included. BTA injections may cause short term reduction of cortical bone
thickness and trabeculation. On the long term, cartilage volume reduction and bone volume loss were evident on the condyle and mandibular angle, at both
injected and non-injected mandibular bone structures. Bone mineral density remained unaffected when only one masticatory muscle was injected but was
reduced when several masticatory muscles were treated with BTA. Several cellular and molecular alterations were noticed in some articles.
Because of evidence of irreversible negative effects of BTA on the underlying structures, possible muscle, bone and cartilage volume reduction should be
communicated to the patients prior to any intervention. Further studies are needed to fully understand the cellular mechanisms and molecular responses
behind this phenomenon.
Keywords: Botulinum toxin – botulinum toxin type A injection – adverse effects – mandibular bone – temporomandibular joint.
IAJD 2020;11(1):37-42.

EFFETS INDÉSIRABLES DES INJECTIONS DE TOXINE BOTULINIQUE
DE TYPE A DANS LES MUSCLES MASTICATOIRES SUR L'OS SOUSJACENT ET LE CARTILAGE: UNE REVUE DE LA LITTÉRATURE
Résumé
Les injections de toxine botulique de type A (BTA) dans les muscles masticateurs sont des procédures cliniques utilisées pour traiter de nombreuses conditions. Cette neurotoxine provoque une paralysie transitoire suivie d’une atrophie des muscles concernés.
Le but de cette revue est de rassembler et de définir les effets des injections de BTA sur les muscles masticateurs ainsi que sur les structures cartilagineuses et osseuses sous-jacentes.
Une recherche électronique des bases de données « Medline » et « Google Scholar » couvrant la période de janvier 2007 à juillet 2019 a été effectuée. Les
articles éligibles ont été sélectionnés en fonction des critères d’inclusion / exclusion.
Quatorze articles ont été inclus. Les injections de BTA peuvent entraîner une réduction à court terme de l’épaisseur et la trabéculation de l’os cortical. À
long terme, la réduction du volume du cartilage et la perte de volume osseux étaient évidentes sur le condyle et l'angle mandibulaire, à la fois dans les
structures osseuses mandibulaires injectées et non injectées. La densité osseuse est affectée uniquement dans les cas où plusieurs muscles sont injectés
simultanément. Plusieurs altérations cellulaires et moléculaires ont été remarquées dans certains articles.
En raison des effets négatifs irréversibles du BTA sur les structures sous-jacentes décrits dans la littérature, une éventuelle réduction du volume des
muscles, des os et du cartilage doit être communiquée aux patients avant toute intervention. D’autres études ultérieures sont nécessaires pour mieux
comprendre les mécanismes cellulaires et les réponses moléculaires à la base de ce phénomène.
Mots-clés : toxine botulique - injection de toxine botulique A - effets indésirables - os mandibulaire - articulation temporo-mandibulaire.
IAJD 2020;11(1):37-42.
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Introduction
Botulinum toxin type A is a metalloprotease produced by clostridium
bacteria [1]. This potent neurotoxin
temporarily
blocks
acetylcholine
release at the presynaptic membrane
of neuromuscular junctions leading
to transient inactivity of the innervated muscles and glands [2]. BTA is the
most widely used Botox preparation
[3, 4]. Scott et al. introduced its use of
for strabismus treatment in 1989 [5]. In
dentistry the use of BTA extended for
several indications such as focal dystonia, dyskinesia, migraine, hemifacial
spasm, contraction of smooth and skeletal muscles, sialorrhea and myalgia
[6, 7].
Botulinum toxin is often injected
in facial muscles, mainly the masseter
and temporal, to treat bruxism, clenching, trismus , repetitive jaw dislocations and temporomandibular joint
disorders [8, 9]. BTA is also indicated
for aesthetic improvement in cases of
masseter hypertrophy. Single or repeated injections may be indicated to
obtain the final result [10].
In animal studies, BTA injections into the masticatory muscles
decreased stress at the periosteum
and reduced muscle contractions and
maximal bite force inducing short term
bone changes [11]. In a pilot study on
human subjects, Raphael et al. [12]
detected reduction of trabecular bone
density in the mandibular condyle of
women after BTA injections.
The aim of this review is to investigate current literature on adverse
effects of repetitive BTA injections
in masticatory muscles for craniomandibular dysfunctions treatment
on the underlying bone and cartilage
structures.

Materials and methods
Studies aiming to assess the effect
of BTA injections in the masticatory
muscles on the mandibular bone
and cartilage, published from January
2007 to July 2019, were sought using
Medline electronic database, with

restrictions to the English language.
A search strategy combining the following Medical Subject Headings
(MeSH), search terms was used:
MeSH
terms:
(“Mandibular
Condyle”[Mesh]) OR “Alveolar Bone
Loss”[Mesh])) OR “Mandible”[Mesh])
OR “Temporomandibular Joint”[Mesh])
OR
“Temporomandibular
Joint
Disc”[Mesh]) AND “Botulinum Toxins,
Type A”[Mesh]) OR “Botulinum
Toxins”[Mesh]) AND “adverse effects”
[Subheading].
In addition, a Google Scholar
search was performed to identify other
relevant studies. Two authors screened the titles and abstracts of the
identified articles in the initial search.
Irrelevant publications were excluded
and potential articles were required to
meet the inclusion/exclusion criteria
to be eligible for critical appraisal.
The inclusion criteria for studies to
be considered were:
- Randomized and quasi-randomized
controlled trials, including parallel studies or cross-over studies
having a wash-out period of at least
3 months.
- Human and animal participants.
- Injections of BT injection type A,
irrespective of dose.
-
Injections in all masticatory
muscles.
- Presence of a control group with
any alternative intervention or
placebo.
- Bone parameters assessed by histomorphometry, bone mineral density (BMD) and microtomography
(micro CT) as primary outcomes.
The exclusion criteria were:
-
Previously published literature
or systematic reviews and thesis
abstracts.
-
Injections of Botox types B, C-1,
C-2, D, E, F, or G.
Eligible articles were then reviewed
independently in full text version by
two examiners.

Data extraction
Study details were extracted and
entered into data collection forms.
The following characteristics were
recorded: (1) title and publication
date; (2) specie, and number of participants; (3) dosage, of BTA; (4) outcome
measurement methods; (5) interval
and length of follow-up

Results
Search outcome
Figure 1 illustrates the search strategy that yielded a total of 159 articles.
After evaluating the titles and abstracts,
138 articles were excluded for nonrelevance, and 21 full-text articles were
assessed for eligibility by two authors.
After review of full-texts, 7 articles were
excluded with the following reasons:
pilot study (one article), a prospective
cohort (three articles), reviews (one
article) and ineligible diagnosis based
on TMD arthralgia or esthetic masseteric hypertrophy (two articles). A total of
fourteen randomized controlled trials
were finally included in this review and
processed for critical appraisal. A summary of the selected studies is presented in table 1.
Effects of BTA on mandibular bone
density
Two randomized controlled studies evaluated the effect of BTA on
bone mineral density (BMD) compared
with a control group (saline). In 2010,
a study conducted on 10 old SpragueDawley rats showed significant bone
mineral density difference in unilateral injected BTA side compared with
that of the saline injected side 90 days
after injections [13]. Similar results
were obtained in the study of Tsai et al.
[22] conducted on 60 adult rats. In the
group where BTA was injected in either
the masseter or temporalis alone the
difference with the control saline group
was not significant. Nevertheless, in a
group where BTA was injected in both
masseter and temporalis muscles,
BMD of the mandible was 5.71 per cent
less than that of the control group.
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159 articles identified through
database searching (Medline)

6 additional articles identified through other sources

159 articles for screening
after duplicates removal
138 articles were excluded
after evaluation of title/abstract
(non-relevance)

21 full-text articles
assessed for eligibility

14 studies included
in this review

7 articles excluded after review
of full paper, with reasons:
pilot study (n=1)
cohort study (n=3)
inelegible diagnosis (n=2) //
aesthetic reviews (n=1)

Fig. 1: PRISMA flow diagram.

Title, Journal and Year

Subjects

Dosage

Method of
measurement

Time of
measurement

Morphologic and bony structural changes in the
mandible after a unilateral injection of botulinum
neurotoxin in adult rats.
Journal of Oral Maxillofacial Surgery (2010) [13].

Ten male 60-dayold SpragueDawley rats

25 U/mL (0.3 mL)

BMD

90 days after the
procedure

Bone and cartilage changes in rabbit mandibular
condyles after 1 injection of botulinum toxin.
American Journal Orthodontics and Dentofacial
Orthopedics (2015)[14].

50 females
New Zealand
rabbits

10 units

BMD

4 or 12 weeks
after the injection

Mandibular bone effects of botulinum toxin injections in masticatory muscles in adult.
Oral Surgery Oral Medicine Oral Pathology Oral
Radiology (2019) [15].

Twelve adult
patients

100 U: 30 U for
each masseter
and 20 U for each
temporalis

CBCT

12 months after
the injection

Botulinum toxin in masticatory muscles: Short- and
long-term effects on muscle, bone, and craniofacial
function in adult rabbits. Bone (2011) [16].

41 female New
Zealand white
rabbits

10 units (0.25ml)

CT-Scan

4 and 12 weeks
after the injection

Botulinum toxin in masticatory muscles of the adult
rat induces bone loss at the condyle and alveolar
regions of the mandible associated with a bone
proliferation at a muscle enthesis.
Bone (2015) [17].

15 analysis of
mandibular 3D
porosity by a
vector projection
algorithm

1 unit in 0.2ml in
the masseter and
1 unit (in 0.2Ml) in
the temporalis

Analysis of mandibular 3D porosity
by a vector
projection algorithm, CT-Scan,
Micro-CT

4 weeks after
injection

Condylar degradation from decreased occlusal
loading following masticatory muscle atrophy.
Hindawi (2018) [18].

Sixty 5-week-old
female
Sprague-Dawley
rats

2 units

Micro-CT, histological assessment
and immunohistochemical
staining

4 weeks after
injection

Contrast enhancement with uranyl acetate allows
quantitative analysis of the articular cartilage by
micro CT: Application to mandibular condyles in the
BTX rat model of disuse. Micron (2017) [19].

11 eighteen
weeks-old male
Sprague-Dawley
rats

2 units (0.4 ml)

Micro-CT

4 weeks after
injection

Loading of the condylar cartilage can rescue the
effects of Botox on TMJ.
Calcified Tissue International (2018) [20].

24 6-week-old
females

0.3 U, volume of
30 μl

Micro-CT, histological staining

4 weeks after
injection
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Bone loss after temporarily induced muscle paralysis
by Botox is not fully recovered after 12 Weeks.
Annals of The New York Academy of Sciences
(2007) [21].

16 4-month-old
mice in a C57BL/6
background

2U/100 g

BMC

12 weeks after
injection

Bone changes in the mandible following botulinum neurotoxin injections. European Journal of
Orthodontics (2011) [22].

Sixty 30-day-old
male Long-Evans
rats

2.5 ml of 25 U/ml

Cortical bone thickness and BMD

45 days after the
injection

Repeated injections of botulinum toxin into the
masseter muscle induces bony changes in human
adults: A longitudinal study.
The Korean Journal of Orthodontics (2017) [23].

10 human
patients.

25 IU (0.5 mL) per
muscle

CBCT

6 months after
the injection

Cellular and matrix response of the mandibular
condylar cartilage to Botulinum toxin.
Plos One (2016) [24].

13 5-week-old
transgenic mice
(Col10a1) on a
CD-1 background

0.3 unit: volume
of 30 μl

Micro-CT, histological examination

30 days after the
injection

Early molecular response and micro anatomical
changes in the masseter muscle and mandibular
head after botulinum toxin intervention in adult mice.
Annals of Anatomy (2018) [25].

16 adult male
BALB/c mice

0.2 U

histomorphometric analysis,
qPCR

14 days after the
intervention

Masseter muscle atrophy impairs bone quality of
the mandibular condyle but not the alveolar process
early after induction.
Journal of oral rehabilitation (2019) [26].

18 adult male
BALB/c mice

10 μl

micro CT

14 days after the
intervention

Table 1: Summary of selected articles.

This difference was statistically significant [22].
Cortical bone thickness
In the study of Tsai et al. (2010) [13]
the cortical bone showed a clear thickness reduction, in the area surrounding the BTA injection site, 4 weeks
after injection. At 12 weeks, the bone
showed some clear signs of a partial
recovery of the losses.
Bone trabeculation
In 2012, Rafferty et al. [16] indicated significant differences in the bone
trabeculation. 4 weeks after injections
test groups showed almost 3 times less
trabeculations than control groups.
Some improvement was shown 12
weeks after injections.
Mandibular bone volume
According to a study on human
subjects, Lee et al. [23] indicated significant volume loss in the mandibular
angle area, 6 months after injection.
Alveolar bone volume
During a study on 41 rabbits who
received a one-sided, single masse-

teric injection, both the injected and
the non-injected sides showed significant alveolar bone volume reduction
at 4 weeks after the procedure. These
changes were still present at 12 weeks;
however, they became statistically insignificant [16].
Condylar bone volume
Through Micro-CT and condylar
morphometry, bone volume loss was
evident in the injected site at 4 weeks,
12 weeks and a year. According to
Matthys et al. [14] and Shi et al. [18],
this resorption was noted specially in
the anterior part of the condyle. The
non-injected site showed no volume
loss. Balanto-Melo et al. [26] showed
that, after one BTA injection, condyle
bone resorption begins at an early
stage of masseter atrophy, and before
alveolar process alteration.
Cartilage and subchondral bone
Kun-Darbois et al. [27] showed that
after single BTA injection in masseter
or temporalis muscle, cartilage thickness of adult rats did not show significant difference between injected and
non-injected sites. On the other hand,
in a recent study on human subjects

who received one BTA injection, Kahn
A et al. (2019) [15] revealed significant
loss of volume in the cartilage area and
increase of trabeculation in the subchondral bone area 12 months after the
injection. These changes are explained in the study of Dutra el al. [20] by
a decrease in mineralization, matrix
deposition and Tartrate Resistant Acid
Phosphatase (TRAP) activity in the
mandibular condylar cartilage [20].
Effects of BTA on cellular activity and
molecular response
Dutra et al. [24] studied the cellular
and matrix respond of the mandibular
cartilage to BTA injections. Positive
TRAP staining showed a significant
lower percentage of osteoclast activity
in the injected side in comparison to
control, suggesting a lower bone turnover. This bone remodeling decrease
can be explained by immunohistochemistry tests revealing a reduced
expression of Vascular Endothelial
Growth Factor (VEGF), the angiogenic stimulator that attracts osteoblasts, osteoclasts and chondroclasts
during endochondral ossification.
Furthermore, immunohistochemistry
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showed a decreased expression of
pSMAD 1/5/8 on the BTA injected side
signaling an increased proliferation of
chondrocytes. In addition, Toluidine
blue staining showed a decrease of
proteoglycan secretion and Safranin O
staining revealed a marked reduction
of glycosaminoglycans in the mandibular condylar cartilage of the BTA
injected side [24].
Another article conducted by
Balanta-Melo et al. [25] in 2018 studying early molecular response of
the mandibular head revealed that
two days after BTA injection, mRNA
levels of the bone resorption promoter
RANKL showed a 4-fold increase. Also,
histomorphometric analysis showed a
significant reduction in bone per tissue area in the BTA injected side [25].

Discussion
When injected into masticatory
muscles, botulinum toxin type A causes
transient paralysis [2]. According to
the Wolff’s law, mastication muscles
exert stresses at the periosteum and
control bone microarchitecture [28].
Mandibular bone and alveolar processes are stimulated by the mechanical forces of mastication to keep the
teeth and underlying bone healthy.
Therefore, masticatory function and
occlusal forces are correlated with mandibular bone mineral density and cortical bone [22]. This review gathers most
relevant literature that report adverse
effects of BTA injections in facial
muscles. The use of micro CT in most
articles improves and standardizes
the evaluation of bone changes in the
mandible. However, reviewed articles
present heterogeneous study designs
regarding the brand and dosage of BTA
and the type of animals used.
In animal studies, Tsai et al. [13]
showed that after transient muscle
paralysis, injected and non- injected
sites of the same mandible exhibited
losses in cortical thickness due to
reduced muscular activity. Important
reduction of both cortical bone thickness and trabeculation, 4 weeks after
injection, explains the significant loss

of bone volume on different levels:
alveolar, condylar and mandibular
angle. Even though bone thickness
and trabeculation show recovery 12
weeks after injection, bone’s total
volume differences between test and
control groups remain significant on
the long term. These results are in
agreement with two human studies
that confirmed long term reduction of
bone volume after BTA injections. Lee
et al. [23] offered extensive evidence
that bone volume loss persisted for 6
months and Kahn A et al. [15] proved
that the losses remained significant
at1 year after injection. Even though
bone remodeling is much faster in
mice (2 weeks) than in humans (up
to 9 months), the results of these two
studies confirm long term reduction of
bone volume after BTA injections [28].
On the other hand, results concerning bone mineral density reported
in rats did not find any significance
between BTA and saline injected
sites when one masticatory muscle
is injected with BTA. This result may
be explained by the small specimen
(10 old rats), by the long term followup period after a single injection (90
days after injection), or by the parallel
changes of bone volume. BMD changes
are highlighted in the study of Tsai et
al. [22] where groups receiving BTA
injections in only one of the masticatory muscles did not show significant
changes whereas the group receiving
BTA injections in both masseter and
temporal muscles showed significant
BMD reduction. The non-change can
be explained by the compensatory
effect of the non-injected muscles
while the significant change might be
induced by the simultaneous function
reduction of both injected muscles.
Changes in bone biology after BTA
injections were explored using genetically modified mice. Concerning the
long term molecular response, Dutra
el al. [24] conducted a study on transgenic mice and found a decreased
expression of pSMAD 1/5/8 which led
to increased chondrocytes proliferation and a decreased in glycoaminoglycans and proteoglycans distribution.

This study also showed a reduced TRAP
and VEGF activity which indicates less
bone remodeling on the injected side
on the long term. On the other hand,
Balanta-Melo et al. [25] demonstrated a significant decrease in RANKL
expression in mandibular heads as
early as 2 days after injection, which
questions the specific cells concerned
in this early response. RANKL is a promoter of bone resorption and osteoclastogenisis that is increased only in
the first week post-injection based on
the study of Balanta et al. This explains
the bone loss of 30% after 14 days in
the BTA injected mandibular heads.
This effect is in accordance with the
results found in the study of Dutra et
al. [24] on female mice (-21.4%) and
the study of Kun-Darbois et al. [27] on
male rats (-35%) after 4 weeks. A sex
contribution may have contributed in
the outcome difference between male
and female animals. It will be relevant
to establish in the future a relationship
between biochemical factors secreted
by paralysed or atrophied muscles,
decreased mechanical loading and
osteopenia.

Conclusion
The findings of the reviewed
articles suggest that repetitive BTA
injections in masticatory muscles lead
to several adverse effects in the related
structures. A volume reduction of temporomandibular joint’s cartilage, mandibular bone and alveolar process are
presented. These side effects should
be communicated to patients before
any BTA injection in facial masticatory
muscles. Future researches will help to
fully understand the cellular and molecular changes behind these phenomena. Also, new indications and ways
to control the negative effects of BTA
injections are to investigate.
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